Detection of all-cause advanced hepatic fibrosis using an ensemble machine learning framework
- PMID: 35216748
- DOI: 10.1016/S2589-7500(22)00026-7
Detection of all-cause advanced hepatic fibrosis using an ensemble machine learning framework
Conflict of interest statement
I report unrestricted educational grants from Sirtex, Bristol Myers Squibb, and Bayer; lecture fees from Dr Falk and Roche; serving on advisory boards for Bristol Myers Squibb, Sirtex, and Roche; co-writing an article with Bristol Myers Squibb; shares with AstraZeneca; and receiving a meetings pass from Roche to attend a scientific meeting.
Comment on
-
Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study.Lancet Digit Health. 2022 Mar;4(3):e188-e199. doi: 10.1016/S2589-7500(21)00270-3. Lancet Digit Health. 2022. PMID: 35216753
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
